tirzepatide in thigh where to inject Semaglutide Injection Sites: Abdomen vs. Thigh – Which Is Better? Injection site swelling + bruise

Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss

Support for better sleep quality and recovery in some research models

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits

However, as the broad pharmaceutical launch environment continues to become increasingly restrictive, highlighting the key drivers behind the success of Wegovy, Mounjaro, and Zepbound launches can provide critical insights for future strategies

Many people on GLP-1 medications hit a weight loss plateau

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide